Angiogenesis in ischemic tissue produced by spheroid grafting of human adipose-derived stromal cells

Biomaterials

Volumn 32, Issue 11, 2011, Pages 2734-2747

  Bhang, Suk Ho ^a   Cho, Seung Woo ^b   La, Wan Geun ^a   Lee, Tae Jin ^c   Yang, Hee Seok ^c   Sun, Ah Young ^c   Baek, Sang Hong ^d   Rhie, Jong Won ^d   Kim, Byung Soo ^a  

^a Seoul National University   (South Korea)

^b Yonsei University   (South Korea)

^c Hanyang University   (South Korea)

^d The Catholic University of Korea   (South Korea)

Author keywords

Human adipose stromal cells; Spheroid; Therapeutic angiogenesis

Indexed keywords

ADAPTIVE SIGNALS; ANGIOGENESIS; ANGIOGENIC FACTOR; ANOIKIS; ANTI-APOPTOTIC FACTOR; APOPTOSIS; ATHYMIC MICE; BIOMATERIAL SCAFFOLDS; CELL DELIVERY; CELL MATRIX INTERACTIONS; CELL SURVIVAL; ENGRAFTMENT; EXTRACELLULAR MATRICES; FIBROBLAST GROWTH FACTOR 2; GENETIC MODIFICATIONS; GROWTH FACTOR DELIVERY; HEPATOCYTE GROWTH FACTOR; HUMAN ADIPOSE; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIC ENVIRONMENTS; IN-VIVO; ISCHEMIC LIMBS; ISCHEMIC TISSUES; MONOLAYER CULTURE; NEOVASCULARIZATION; PARACRINE; PROTEOLYTIC ENZYME; SPHEROID; STEM CELL THERAPY; STROMAL CELLS; THERAPEUTIC ANGIOGENESIS; THERAPEUTIC EFFICACY; VASCULAR ENDOTHELIAL GROWTH FACTOR;

BIOASSAY; BIOMATERIALS; CELL DEATH; DISEASE CONTROL; GENETIC ENGINEERING; MONOLAYERS; PEPTIDES; PHYSIOLOGY; SCAFFOLDS; STEM CELLS; TISSUE;

CELL CULTURE;

ADIPOSE DERIVED STROMAL CELL; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL SURVIVAL; CELL TRANSPLANTATION; FEMALE; HUMAN; HUMAN CELL; HYPOXIA; LIMB ISCHEMIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPHEROID CELL; STROMA CELL;

ADIPOSE TISSUE; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; ISCHEMIA; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STROMAL CELLS;

MUS;

EID: 79951580027     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.12.035     Document Type: Article

References (47)

1. Cho S.W., Moon S.H., Lee S.H., Kang S.W., Kim J., Lim J.M., et al. Improvement of postnatal neovascularization by human embryonic stem cell derived endothelial-like cell transplantation in a mouse model of hindlimb ischemia. Circulation 2007, 116:2409-2419.
2. Takahashi T., Kalka C., Masuda H., Chen D., Silver M., Kearney M., et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999, 5:434-438.
3. Kinnaird T., Stabile E., Burnett M.S., Lee C.W., Barr S., Fuchs S., et al. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 2004, 94:678-685.
4. Cai L., Johnstone B.H., Cook T.G., Tan J., Fishbein M.C., Chen P.S., et al. IFATS collection: human adipose tissue-derived stem cells induce angiogenesis and nerve sprouting following myocardial infarction, in conjunction with potent preservation of cardiac function. Stem Cells 2009, 27:230-237.
5. Tateishi-Yuyama E., Matsubara H., Murohara T., Ikeda U., Shintani S., Masaki H., et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 2002, 360:427-435.
6. Hill E., Boontheekul T., Mooney D.J. Regulating activation of transplanted cells controls tissue regeneration. Proc Natl Acad Sci USA 2006, 103:2494-2499.
7. Bates R.C., Edwards N.S., Yates J.D. Spheroids and cell survival. Crit Rev Oncol Hematol 2000, 36:61-74.
8. Wang C.C., Chen C.H., Hwang S.M., Lin W.W., Huang C.H., Lee W.Y., et al. Spherically symmetric mesenchymal stromal cell bodies inherent with endogenous extracellular matrices for cellular cardiomyoplasty. Stem Cells 2009, 27:724-732.
9. Zhang M., Methot D., Poppa V., Fujio Y., Walsh K., Murry C.E. Cardiomyocyte grafting for cardiac repair: graft cell death and antideath strategies. J Mol Cell Cardiol 2001, 33:907-921.
10. Robey T.E., Saiget M.K., Reinecke H., Murry C.E. Systems approaches to preventing transplanted cell death in cardiac repair. J Mo Cell Cardiol 2008, 45:567-581.
11. Assmus B., Honold J., Schächinger V., Britten M.B., Fischer-Rasokat U., Lehmann R., et al. Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 2006, 355:1222-1232.
12. Jay S.M., Shepherd B.R., Bertram J.P., Pober J.S., Saltzman W.M. Engineering of multifunctional gels integrating highly efficient growth factor delivery with endothelial cell transplantation. FASEB J 2008, 22(8):2949-2956.
13. Deuse T., Peter C., Fedak P.W., Doyle T., Reichenspurner H., Zimmermann W.H., et al. Hepatocyte growth factor or vascular endothelial growth factor gene transfer maximizes mesenchymal stem cell-based myocardial salvage after acute myocardial infarction. Circulation 2009, 120:S247-S254.
14. Fitzpatrick J.R., Frederick J.R., McCormick R.C., Harris D.A., Kim A.Y., Muenzer J.R., et al. Tissue-engineered pro-angiogenic fibroblast scaffold improves myocardial perfusion and function and limits ventricular remodeling after infarction. J Thorac Cardiovasc Surg 2010, 140(3):667-676.
15. Bhang S.H., Lim J.S., Choi C.Y., Kwon Y.K., Kim B.S. The behavior of neural stem cells on biodegradable synthetic polymers. J Biomater Sci Polym Ed 2007, 18:223-239.
16. Wilson C.A., Cichutek K. The US and EU regulatory perspectives on the clinical use of hematopoietic stem/progenitor cells genetically modified ex vivo by retroviral vectors. Methods Mol Biol 2009, 506:477-488.
17. Korff T., Kimmina S., Martiny-Baron G., Augustin H.G. Blood vessel maturation in a 3-dimensional spheroidal coculture model: direct contact with smooth muscle cells regulates endothelial cell quiescence and abrogates VEGF responsiveness. FASEB J 2001, 15:447-457.
18. Gaedtke L., Thoenes L., Culmsee C., Mayer B., Wagner E. Proteomic analysis reveals differences in protein expression in spheroid versus monolayer cultures of low-passage colon carcinoma cells. J Proteome Res 2007, 6:4111-4118.
19. Datta S.R., Brunet A., Greenberg M.E. Cellular survival: a play in three Akts. Genes Dev 1999, 13(22):2905-2927.
20. Brunet A., Bonni A., Zigmond M.J., Lin M.Z., Juo P., Hu L.S., et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 1999, 96(6):857-868.
21. Basile D.P., Liapis H., Hammerman M.R. Expression of bcl-2 and bax in regenerating rat renal tubules following ischemic injury. Am J Physiol 1997, 272:640-647.
22. Shimizu S., Eguchi Y., Kosaka H., Kamiike W., Matsuda H., Tsujimoto Y. Prevention of Hypoxia induced cell death by Bcl-2 and Bcl-xL. Nature 1995, 374:811-813.
23. Kluck R.M., Bossy-Wetzel E., Green D.R., Newmeyer D.D. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 1997, 275:1132-1136.
24. Jurgensmeier J.M., Xie Z., Deveraux Q., Ellerby L., Bredesen D., Reed J.C. Bax directly induces release of cytochrome c from isolated mitochondria. Proc Natl Acad Sci USA 1998, 95:4997-5002.
25. Antonsson B., Conti F., Ciavatta A., Montessuit S., Lewis S., Martinou I., et al. Inhibition of Bax channel-forming activity by Bcl-2. Science 1997, 277:370-372.
26. Rosová I., Dao M., Capoccia B., Link D., Nolta J.A. Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells. Stem Cells 2008, 26(8):2173-2182.
27. Yoon C.H., Hur J., Oh I.Y., Park K.W., Kim T.Y., Shin J.H., et al. Intercellular adhesion molecule-1 is upregulated in ischemic muscle, which mediates trafficking of endothelial progenitor cells. Arterioscler Thromb Vasc Biol 2006, 26:1066-1072.
28. Koch A.E., Halloran M.M., Haskell C.J., Shah M.R., Polverini P.J. Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature 1995, 376:517-519.
29. Mickanin C., Trask T., Kirschbaum N.E., Newman P.J., Albelda S.M., Buck C. Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31): alternatively spliced, functionally distinct isoforms expressed during mammalian cardiovascular development. Development 1994, 120:2539-2553.
30. Pinter E., Barreuther M., Liu T., Imhof B.A., Madri J.A. Platelet-endothelial cell adhesion molecule-1 (PECAM-1/CD31) tyrosine phosphorylation state changes during vasculogenesis in the murine conceptus. Am J Pathol 1997, 150:1523-1530.
31. Ferrero E., Ferrero M.E., Pardi R., Zocchi M.R. The platelet endothelial cell adhesion molecule-1 (PECAM-1) contributes to endothelial barrier function. FEBS Lett 1995, 374:323-326.
32. Zuk P.A., Zhu M., Ashjian P., De Ugarte D.A., Huang J.I., Mizuno H., et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002, 13:4279-4295.
33. Ryu J.H., Kim S.S., Cho S.W., Choi C.Y., Kim B.S. HEK 293 cell suspension culture using fibronectin-adsorbed polymer nanospheres in serum-free medium. J Biomed Mater Res A 2004, 71:128-133.
34. Gwak S.J., Bhang S.H., Kim I.K., Kim S.S., Cho S.W., Jeon O., et al. The effect of cyclic strain on embryonic stem cell-derived cardiomyocytes. Biomaterials 2008, 29:844-856.
35. Bhang S.H., Cho S.W., Lim J.M., Kang J.M., Lee T.J., Yang H.S., et al. Locally-delivered growth factor enhances the angiogenic efficacy of adipose-derived stromal cells transplanted to ischemic limbs. Stem Cells 2009, 27:1976-1986.
36. Pugh C.W., Ratcliffe P.J. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med 2003, 9:677-684.
37. Ceradini D.J., Kulkarni A.R., Callaghan M.J., Tepper O.M., Bastidas N., Kleinman M.E., et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 2004, 10:858-864.
38. Zuk P.A., Zhu M., Mizuno H., Huang J., Futrell J.W., Katz A.J., et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001, 7:211-228.
39. Entenmann G., Hauner H. Relationship between replication and differentiation in cultured human adipocyte precursor cells. Am J Physiol 1996, 270:C1011-C1016.
40. Tapp H., Hanley E.N., Patt J.C., Gruber H.E. Adipose-derived stem cells: characterization and current application in orthopaedic tissue repair. Exp Biol Med 2009, 234:1-9.
41. Cai L., Johnstone B.H., Cook T.G., Liang Z., Traktuev D., Cornetta K., et al. Suppression of hepatocyte growth factor production impairs the ability of adipose-derived stem cells to promote ischemic tissue revascularization. Stem Cells 2007, 25:3234-3243.
42. Glicklis R., Merchuk J.C., Cohen S. Modeling mass transfer in hepatocyte spheroids via cell viability, spheroid size, and hepatocellular functions. Biotechnol Bioeng 2004, 86:672-680.
43. Ward J.P., King J.R. Mathematical modelling of drug transport in tumour multicell spheroids and monolayer cultures. Math Biosci 2003, 181:177-207.
44. Rehman J., Traktuev D., Li J., Merfeld-Clauss S., Temm-Grove C.J., Bovenkerk J.E., et al. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 2004, 109:1292-1298.
45. Frisch S.M., Screaton R.A. Anoikis mechanisms. Curr Opin Cell Biol 2001, 13:555-562.
46. Frisch S.M., Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 1994, 124:619-626.
47. Traktuev D.O., Merfeld-Clauss S., Li J., Kolonin M., Arap W., Pasqualini R., et al. A population of multipotent CD34-positive adipose stromal cells share pericyte and mesenchymal surface markers, reside in a periendothelial location, and stabilize endothelial networks. Circ Res 2008, 102:77-85.